anti-CD66b antibody [B13.9]

anti-CD66b antibody [B13.9] for Flow cytometry,ICC/IF and Human

publication_link Publication1


Product Description

Mouse Monoclonal antibody [B13.9] recognizes CD66b

Tested Reactivity Hu
Tested Application FACS, ICC/IF
Specificity The monoclonal antibody reacts with 100% of mature human granulocytes. The monoclonal antibody does not react with normal human peripheral B-cells, T-cells, monocytes and platelets.
Host Mouse
Clonality Monoclonal
Clone B13.9
Isotype IgG1
Target Name CD66b
Antigen Species Human
Immunogen Human granulocytes
Conjugation Un-conjugated
Alternate Names CD67; NCA-95; CD67 antigen; CGM6; CD66b; Carcinoembryonic antigen-related cell adhesion molecule 8; Carcinoembryonic antigen CGM6; Non-specific cross-reacting antigen NCA-95; CD antigen CD66b

Application Instructions

Application Suggestion
Tested Application Dilution
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.


Form Liquid
Purification Purified by ammonium sulfate precipitation through ion exchange chromatography.
Buffer PBS (pH 7.4) and 15 mM Sodium azide.
Preservative 15 mM Sodium azide
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.


Database Links

GeneID: 1088 Human CEACAM8

Swiss-port # P31997 Human Carcinoembryonic antigen-related cell adhesion molecule 8

Gene Symbol CEACAM8
Gene Full Name carcinoembryonic antigen-related cell adhesion molecule 8
Calculated MW 38 kDa

Specific References

Stromal Neutrophil Extracellular Trap Density Is an Independent Prognostic Factor for Cervical Cancer Recurrence

IHC-P / Human

Bin Yan et al.
Front Oncol.,  (2021)